Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 70751 - 70775 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	GLI1	2735	upregulated	Silicon Dioxide analog results in increased expression of GLI1 mRNA	12q13.3	A24194
Silicon dioxide	Approved	GLI2	2736	downregulated	Silicon Dioxide analog results in decreased expression of GLI2 mRNA	2q14.2	A24194
Silicon dioxide	Approved	GLIPR1	11010	upregulated	Silicon Dioxide results in increased expression of GLIPR1 mRNA	12q21.2	A24196
Silicon dioxide	Approved	GLIPR1L2	144321	downregulated	Silicon Dioxide analog results in decreased expression of GLIPR1L2 mRNA	12q21.2	A24195
Silicon dioxide	Approved	GLMP	112770	upregulated	Silicon Dioxide analog results in increased expression of GLMP mRNA	1q22	A24195
Silicon dioxide	Approved	GLO1	2739	downregulated	Silicon Dioxide results in decreased expression of GLO1 mRNA	6p21.2	A24209
Silicon dioxide	Approved	GLP2R	9340	downregulated	Silicon Dioxide analog results in decreased expression of GLP2R mRNA	17p13.1	A24195
Silicon dioxide	Approved	GLRX3	10539	upregulated	Silicon Dioxide analog results in increased expression of GLRX3 mRNA	10q26.3	A24195
Silicon dioxide	Approved	GLS	2744	upregulated	Silicon Dioxide results in increased expression of GLS mRNA	2q32.2	A24196
Silicon dioxide	Approved	GLS2	27165	downregulated	Silicon Dioxide analog results in decreased expression of GLS2 mRNA	12q13.3	A24195
Silicon dioxide	Approved	GLT8D2	83468	downregulated	Silicon Dioxide analog results in decreased expression of GLT8D2 mRNA	12q23.3	A24195
Silicon dioxide	Approved	GLUL	2752	downregulated	Silicon Dioxide analog results in decreased expression of GLUL mRNA	1q25.3	A24195
Silicon dioxide	Approved	GLUL	2752	downregulated	Silicon Dioxide results in decreased expression of GLUL mRNA	1q25.3	A24196
Silicon dioxide	Approved	GLYAT	10249	downregulated	Silicon Dioxide analog results in decreased expression of GLYAT mRNA	11q12.1	A24195
Silicon dioxide	Approved	GLYATL1	92292	downregulated	Silicon Dioxide analog results in decreased expression of GLYATL1 mRNA	11q12.1	A24194
Silicon dioxide	Approved	GMDS	2762	downregulated	Silicon Dioxide analog results in decreased expression of GMDS mRNA	6p25.3	A24195
Silicon dioxide	Approved	GMFG	9535	upregulated	Silicon Dioxide analog results in increased expression of GMFG mRNA	19q13.2	A24195
Silicon dioxide	Approved	GNA14	9630	downregulated	Silicon Dioxide analog results in decreased expression of GNA14 mRNA	9q21.2	A24195
Silicon dioxide	Approved	GNAL	2774	downregulated	Silicon Dioxide results in decreased expression of GNAL mRNA	18p11.21	A24196
Silicon dioxide	Approved	GNB3	2784	upregulated	Silicon Dioxide analog results in increased expression of GNB3 mRNA	12p13.31	A24195
Silicon dioxide	Approved	GNG2	54331	downregulated	Silicon Dioxide analog results in decreased expression of GNG2 mRNA	14q22.1	A24195
Silicon dioxide	Approved	GNG2	54331	upregulated	Silicon Dioxide analog results in increased expression of GNG2 mRNA	14q22.1	A24194
Silicon dioxide	Approved	GNG3	2785	downregulated	Silicon Dioxide analog results in decreased expression of GNG3 mRNA	11q12.3	A24195
Silicon dioxide	Approved	GNG4	2786	upregulated	Silicon Dioxide analog results in increased expression of GNG4 mRNA	1q42.3	A24194
Silicon dioxide	Approved	GNGT1	2792	upregulated	Silicon Dioxide analog results in increased expression of GNGT1 mRNA	7q21.3	A24194

Displaying entries 70751 - 70775 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability